On The Pen GLP-1 News

On The Pen GLP-1 News

Dave Knapp GLP-1 Industry Insider 205 - $50 Zepbound Incoming? China Has US in a GLP-1 “Chokehold”

On The Pen is the leading GLP-1 news podcast and platform covering obesity medicine, FDA actions, drug shortages, access policy, and the business of NuSH therapies. The podcast is in the top 1% of all podcasts globally, and On The Pen is a top Substack best-seller.


00:00
00:00

單集

205-

$50 Zepbound Incoming? China Has US in a GLP-1 “Chokehold”

18 Aug 2026
204-

200 GLP-1 Deaths, Chrissy Metz & a Stunning Harvard Study

12 Aug 2026
203-

Eli Lilly Earnings Call Recap: Retatrutide News

07 Aug 2026
202-

Novo Nordisk Warned us For Years About Synthesized Semaglutide. Now They Want In.

04 Aug 2026
201-

Retatrutide Biologic Battle: The Story Gets Bigger

28 Jul 2026